Pretreatment HDL‐C and ApoA1 are predictive biomarkers of progression‐free survival in patients with EGFR mutated advanced non‐small cell lung cancer treated with TKI.
Saved in:
| Title: | Pretreatment HDL‐C and ApoA1 are predictive biomarkers of progression‐free survival in patients with EGFR mutated advanced non‐small cell lung cancer treated with TKI. |
|---|---|
| Authors: | Ma, Juan1 (AUTHOR), Bai, Ying2 (AUTHOR), Liu, Mei2 (AUTHOR), Jiao, Tong2 (AUTHOR), Chen, Yang2 (AUTHOR), Yuan, Bo2 (AUTHOR), Liu, Boxuan2 (AUTHOR), Zeng, Lizhong2 (AUTHOR), Ming, Zongjuan2 (AUTHOR), Li, Wei2 (AUTHOR), Sun, Ruiying2 (AUTHOR), Yang, Xia2 (AUTHOR), Yang, Shuanying2 (AUTHOR) yangshuanying66@163.com |
| Source: | Thoracic Cancer. Apr2022, Vol. 13 Issue 8, p1126-1135. 10p. |
| Database: | Academic Search Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
| ISSN: | 17597706 |
|---|---|
| DOI: | 10.1111/1759-7714.14367 |
